UHMS Hyperbaric Oxygen Therapy Indications 14th Edition Coming Summer 2019
The UHMS Hyperbaric Oxygen Therapy Indications has served as a guidance for practitioners and scientists interested in hyperbaric and undersea medicine since 1977. Additionally, this document continues to be used by the Centers for Medicare and Medicaid Services and other third-party insurance carriers in determining payment. To date, the committee recognizes 14 indications for which scientific and clinical evidence supports the use of HBO2.
The upcoming 14th edition, due for publication in the summer of 2019, has grown in size and depth, and includes the following updates:
- • revised and updated references
- • a new chapter summarizing recently published data on trials of HBO2 for chronic traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD)
- • addition of flowcharts to specific chapters to aid in treatment decision-making
The Undersea and Hyperbaric Medical Society maintains its reputation for its expertise on hyperbaric therapy. Richard E. Moon, chair of the Hyperbaric Oxygen Therapy Committee and editor for the 14th edition, along with additional Committee members and leading experts in the field, author chapters in their respective fields. This publication continues to provide the most current and up-to-date guidance and support in hyperbaric medicine.